Skip to main content
. 2022 Jun 16;146(3):265–275. doi: 10.1111/ane.13659

FIGURE 1.

FIGURE 1

Cenobamate titration schedule during the double‐blind treatment period of (A) study C013, (B) study C017, and (C) open‐label study C021. *The initial starting dose of cenobamate in the original faster titration schedule was 100 mg/day, with weekly increments of 100 mg/day to the target dose. The amended titration schedule reduced the initial starting dose to 50 mg/day and slowed the titration rate to the target dose to improve tolerability